Sign in
4

Changes in Ownership

Arcus Biosciences, Inc. Filed Acc 0001724521-23-000076

Chief Operating Officer sold 21,521 shares at $17.76 ($382,213)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Jarrett Jennifer · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-12-22 Sale : show line 1 in the form 10b5-1 −21,521 $17.76 $382,213 258,878 D
Open-market sales · 21,521 sh · avg $17.76 · $382,213
Loading xslF345X05/wk-form4_1703624687.xml…